5. Combinational therapy: Melatonin therapy with accessory
therapeutic agents
Based on the aforementioned studies we propose melatonin therapy to
inhibit inflammatory cytokine secretion and alleviate atherosclerosis by
regulating macrophage mitophagy. However, for optimal management of
mitophagy, accessory therapeutic agents could be used alongside with
melatonin therapy, forming combinational therapeutic systems.